- Home
- ARDX vs PAXS Comparison
ARDX vs PAXS Comparison
Compare ARDX & PAXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARDX
- PAXS
- Stock Information
- Founded
- ARDX 2007
- PAXS 2021
- Country
- ARDX United States
- PAXS United States
- Employees
- ARDX N/A
- PAXS N/A
- Industry
- ARDX Biotechnology: Pharmaceutical Preparations
- PAXS Investment Managers
- Sector
- ARDX Health Care
- PAXS Finance
- Exchange
- ARDX Nasdaq
- PAXS Nasdaq
- Market Cap
- ARDX 882.9M
- PAXS 723.1M
- IPO Year
- ARDX 2014
- PAXS N/A
- Fundamental
- Price
- ARDX $6.52
- PAXS $16.18
- Analyst Decision
- ARDX Strong Buy
- PAXS
- Analyst Count
- ARDX 9
- PAXS 0
- Target Price
- ARDX $10.50
- PAXS N/A
- AVG Volume (30 Days)
- ARDX 3.5M
- PAXS 195.0K
- Earning Date
- ARDX 10-30-2025
- PAXS 01-01-0001
- Dividend Yield
- ARDX N/A
- PAXS 11.72%
- EPS Growth
- ARDX N/A
- PAXS N/A
- EPS
- ARDX N/A
- PAXS N/A
- Revenue
- ARDX $386,146,000.00
- PAXS N/A
- Revenue This Year
- ARDX $16.83
- PAXS N/A
- Revenue Next Year
- ARDX $28.55
- PAXS N/A
- P/E Ratio
- ARDX N/A
- PAXS N/A
- Revenue Growth
- ARDX 83.88
- PAXS N/A
- 52 Week Low
- ARDX $3.21
- PAXS $12.57
- 52 Week High
- ARDX $7.18
- PAXS $15.93
- Technical
- Relative Strength Index (RSI)
- ARDX 79.80
- PAXS 81.57
- Support Level
- ARDX $6.38
- PAXS $15.46
- Resistance Level
- ARDX $6.65
- PAXS $16.06
- Average True Range (ATR)
- ARDX 0.22
- PAXS 0.12
- MACD
- ARDX 0.00
- PAXS 0.03
- Stochastic Oscillator
- ARDX 85.53
- PAXS 91.68
About ARDX Ardelyx Inc.
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.
About PAXS PIMCO Access Income Fund of Beneficial Interest
PIMCO Access Income Fund is a non-diversified, limited-term, closed-end management investment company. The fund seeks current income as an objective and capital appreciation as a secondary objective. It achieves the investment objectives by utilizing a dynamic asset allocation among multiple sectors in the public and private credit markets, including corporate debt.